taking tirzepatide People Who Stopped the Weight Loss Drug Regained Nearly Half the Weight They Lost TrimRX | How to Take

GLP-1 medications carry risks including gastrointestinal symptoms, pancreatitis, and gallbladder disease, requiring specialist supervision

NEW: Oral Wegovy (pill form) FDA approved December 2025

Other study examining the association between GLP-1 RAs and cholangiocarcinoma did not find a significant increase in risk with their use, although 26 cases were reported, failing to establish a statistically significant association between GLP-1 RA use and increased risk (Ueda et al., 2021)

Potential Benefits for Non-Alcoholic Fatty Liver Disease (NAFLD) : Preliminary studies suggest Semaglutide may help reduce liver fat content and improve liver function in individuals with NAFLD, which is closely linked to obesity and type 2 diabetes

If youve truly tried lifestyle modifications without success, say so clearly: I appreciate that, and I want you to know Ive been working on this for years